Abstract

The present invention relates to an isolated CD31+ cell derived from adipose-derived regenerative cells (ADRC's), for use as a medicament. The invention also relates to compositions comprising such cells. In addition, the invention relates to methods for screening for the regenerative capacity of a population of adipose-derived regenerative cells (ADRC's).
OriginalsprogEngelsk
IPCA61K35/16,A61K38/19,A61P15/10
PatentnummerWO2019193052 (A1)
Journaliseringsdato10/10/2019
Land/OmrådeDanmark
Prioritetsdato04/04/2018
PrioritetsnummerDKPA201870194A
StatusUdgivet - 10. okt. 2019

Fingeraftryk

Dyk ned i forskningsemnerne om 'Stem cells and progenitor cells bearing CD31'. Sammen danner de et unikt fingeraftryk.

Citationsformater